217 related articles for article (PubMed ID: 31386938)
1. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
[TBL] [Abstract][Full Text] [Related]
2. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
[TBL] [Abstract][Full Text] [Related]
3. The
Almkvist O; Graff C
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946903
[TBL] [Abstract][Full Text] [Related]
4. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.
Almkvist O; Johansson C; Laffita-Mesa J; Thordardottir S; Graff C
Eur J Neurol; 2022 Dec; 29(12):3580-3589. PubMed ID: 36039401
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.
Aguirre-Acevedo DC; Lopera F; Henao E; Tirado V; Muñoz C; Giraldo M; Bangdiwala SI; Reiman EM; Tariot PN; Langbaum JB; Quiroz YT; Jaimes F
JAMA Neurol; 2016 Apr; 73(4):431-8. PubMed ID: 26902171
[TBL] [Abstract][Full Text] [Related]
7. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
[TBL] [Abstract][Full Text] [Related]
8. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
[TBL] [Abstract][Full Text] [Related]
9. Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
Almkvist O; Larsson M; Graff C
J Alzheimers Dis; 2024; 97(2):587-598. PubMed ID: 38160354
[TBL] [Abstract][Full Text] [Related]
10. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Schultz SA; Shirzadi Z; Schultz AP; Liu L; Fitzpatrick CD; McDade E; Barthelemy NR; Renton A; Esposito B; Joseph-Mathurin N; Cruchaga C; Chen CD; Goate A; Allegri RF; Benzinger TLS; Berman S; Chui HC; Fagan AM; Farlow MR; Fox NC; Gordon BA; Day GS; Graff-Radford NR; Hassenstab JJ; Hanseeuw BJ; Hofmann A; Jack CR; Jucker M; Karch CM; Koeppe RA; Lee JH; Levey AI; Levin J; Martins RN; Mori H; Morris JC; Noble J; Perrin RJ; Rosa-Neto P; Salloway SP; Sanchez-Valle R; Schofield PR; Xiong C; Johnson KA; Bateman RJ; Sperling RA; Chhatwal JP;
Aging Cell; 2023 Aug; 22(8):e13871. PubMed ID: 37291760
[TBL] [Abstract][Full Text] [Related]
11. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
12. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.
Day GS; Musiek ES; Roe CM; Norton J; Goate AM; Cruchaga C; Cairns NJ; Morris JC
JAMA Neurol; 2016 Sep; 73(9):1125-32. PubMed ID: 27454811
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
[TBL] [Abstract][Full Text] [Related]
15. Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.
Armstrong GW; Kim LA; Vingopoulos F; Park JY; Garg I; Kasetty M; Silverman RF; Zeng R; Douglas VP; Lopera F; Baena A; Giraldo M; Norton D; Cronin-Golomb A; Arboleda-Velasquez JF; Quiroz YT; Miller JB
JAMA Ophthalmol; 2021 Jan; 139(1):49-56. PubMed ID: 33180114
[TBL] [Abstract][Full Text] [Related]
16. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
[TBL] [Abstract][Full Text] [Related]
17. Early onset familial Alzheimer's disease: Mutation frequency in 31 families.
Janssen JC; Beck JA; Campbell TA; Dickinson A; Fox NC; Harvey RJ; Houlden H; Rossor MN; Collinge J
Neurology; 2003 Jan; 60(2):235-9. PubMed ID: 12552037
[TBL] [Abstract][Full Text] [Related]
18. Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease.
Vannini P; Hanseeuw BJ; Gatchel JR; Sikkes SAM; Alzate D; Zuluaga Y; Moreno S; Mendez L; Baena A; Ospina-Lopera P; Tirado V; Henao E; Acosta-Baena N; Giraldo M; Lopera F; Quiroz YT
JAMA Netw Open; 2020 Dec; 3(12):e2027472. PubMed ID: 33263761
[TBL] [Abstract][Full Text] [Related]
19. Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
O'Connor A; Pannee J; Poole T; Arber C; Portelius E; Swift IJ; Heslegrave AJ; Abel E; Willumsen N; Rice H; Weston PSJ; Ryan NS; Polke JM; Nicholas JM; Mead S; Wray S; Chávez-Gutiérrez L; Frost C; Blennow K; Zetterberg H; Fox NC
Brain; 2021 Nov; 144(10):2964-2970. PubMed ID: 33892504
[TBL] [Abstract][Full Text] [Related]
20. The effects of different familial Alzheimer's disease mutations on APP processing in vivo.
Thordardottir S; Kinhult Ståhlbom A; Almkvist O; Thonberg H; Eriksdotter M; Zetterberg H; Blennow K; Graff C
Alzheimers Res Ther; 2017 Feb; 9(1):9. PubMed ID: 28209190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
